Choose a language and wait for the translated text.
The country's largest drugmaker closed a syndication of a near-$12 billion, 18-month bridge loan earlier this year for Organon's acquisition. The syndication also included State Bank of India, the country's largest lender by assets, the sources said.
Sun Pharma plans $1 billion local debt sale for loan takeout, sources say | PharmaVoice
